[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595442":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":41,"centralContacts":45,"locations":55,"responsibleParty":107,"collaborators":27,"id":109,"slug":110,"hasResults":111,"nctId":112,"briefTitle":113,"officialTitle":114,"acronym":27,"eligibilityCriteria":115,"healthyVolunteers":111,"sex":116,"minAge":117,"maxAge":27,"enrollmentInfo":118,"targetDuration":27,"studyType":121,"phases":122,"briefSummary":124,"conditions":125,"keywords":127,"overallStatus":77,"whyStopped":27,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Weill Medical College of Cornell University","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention A:Intraoperative placement of an inflated intrauterine pediatric foley catheter","EXPERIMENTAL","Intraoperative placement of an inflated intrauterine pediatric foley catheter balloon to remain in place for 7-10 days following surgery.",[13,14,15],"Procedure: Intraoperative placement of an inflated intrauterine pediatric foley catheter","Drug: Hormonal Therapy Agent","Drug: Oral antibiotics",{"label":17,"type":18,"description":19,"interventionNames":20},"Intervention B: No placement of placement of an inflated intrauterine pediatric foley catheter","ACTIVE_COMPARATOR","No placement of an inflated intrauterine pediatric foley catheter",[21,14],"Procedure: No Catheter placement",[23,28,32,37],{"type":24,"name":25,"description":11,"armGroupLabels":26,"otherNames":27},"PROCEDURE","Intraoperative placement of an inflated intrauterine pediatric foley catheter",[9],null,{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"No Catheter placement","No Intraoperative placement of an inflated intrauterine pediatric foley catheter balloon",[17],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"DRUG","Hormonal Therapy Agent","2 weeks of oral estradiol (2 mg daily) or transdermal (two 0.1 mg patches changed twice weekly) estradiol supplementation followed by 1 week of oral or transdermal estradiol (same dosing as above) with oral medroxyprogesterone acetate (10 mg daily)",[9,17],{"type":33,"name":38,"description":39,"armGroupLabels":40,"otherNames":27},"Oral antibiotics","100 mg of oral doxycycline twice daily or other appropriate antibiotic in allergic patients to be given while the intrauterine stent is in place",[9],[42],{"name":43,"affiliation":5,"role":44},"Glenn Schattman, MD","PRINCIPAL_INVESTIGATOR",[46,51],{"name":47,"role":48,"phone":49,"phoneExt":27,"email":50},"Rodriq Stubbs, NP, MSN","CONTACT","646-962-3276","res2011@med.cornell.edu",{"name":52,"role":48,"phone":53,"phoneExt":27,"email":54},"Sarah Cambria","646-962-2961","sac7011@med.cornell.edu",[56,75,90],{"facility":57,"status":58,"city":59,"state":60,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"Arkansas Fertility & Gynecology","NOT_YET_RECRUITING","Little Rock","Arkansas","72205-0000","United States","US",{"type":65,"coordinates":66},"Point",[67,68],-92.28959,34.74648,{"lat":68,"lon":67},[71,74],{"name":72,"role":48,"phone":73,"phoneExt":27,"email":50},"Christopher Moutos, MD","(501) 534-3764",{"name":72,"role":44,"phone":27,"phoneExt":27,"email":27},{"facility":76,"status":77,"city":78,"state":78,"zip":79,"country":62,"countryCode":63,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Weill Cornell Medicine","RECRUITING","New York","10021",{"type":65,"coordinates":81},[82,83],-74.00597,40.71427,{"lat":83,"lon":82},[86,89],{"name":87,"role":48,"phone":27,"phoneExt":27,"email":88},"Rodriq Stubbs, NP","res2011@med.conrell.edu",{"name":43,"role":44,"phone":27,"phoneExt":27,"email":27},{"facility":91,"status":58,"city":92,"state":93,"zip":94,"country":62,"countryCode":63,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"University Hospitals","Cleveland","Ohio","44195",{"type":65,"coordinates":96},[97,98],-81.69541,41.4995,{"lat":98,"lon":97},[101,105],{"name":102,"role":48,"phone":103,"phoneExt":27,"email":104},"Mindy Christianson, MD","(216) 672-1427","christm12@ccf.org",{"name":106,"role":44,"phone":27,"phoneExt":27,"email":27},"Christianson, MD",{"type":108,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100595442","intrauterine-stent-placement-following-hysteroscopic-septum-resection-100595442",false,"NCT07032506","Intrauterine Stent Placement Following Hysteroscopic Septum Resection","A Randomized Controlled Trial of Intrauterine Stent Placement Following Hysteroscopic Septum Resection","Inclusion Criteria:\n\n* Age 18 and above\n* Patients electing to undergo hysteroscopic septoplasty following an informed consent and shared decision making process\n* Uterine septum of at least 50% of the uterine cavity length as quantified on 3-dimensional saline infusion ultrasound\n\nExclusion Criteria:\n\n* Unwilling or unable to provide informed consent\n* History of prior uterine septum resection\n* History of prior transmural uterine surgery\n* Preexisting intrauterine adhesions or prior treatment for intrauterine adhesions\n* Individuals in whom complete septum resection is unable to be performed as a single procedure","FEMALE","18 Years",{"count":119,"type":120},320,"ESTIMATED","INTERVENTIONAL",[123],"NA","The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.",[126],"Intrauterine Adhesion",[128,129,130,131],"intrauterine foley balloon catheter stent","uterine malformations","uterine septums","hysteroscopic septoplasty","2026-06-11",{"date":134,"type":135},"2026-06-12","ACTUAL",{"date":137,"type":135},"2026-05-14",{"date":139,"type":120},"2031-12-31",{"name":5,"class":6},3]